Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient-Ventilator Interaction During Noninvasive Ventilation.

Respiratory care·2025

Same author

Maximizing Extubation Outcomes Through Educational and Organizational Research (METEOR) Trial: protocol for a batched, stepped-wedge, cluster-randomised, type 2 hybrid effectiveness-implementation trial.

BMJ open·2025

Same author

A Randomized, Double-Blind Crossover Study of Change in Post-Dose Lung Function with Hydrofluoroolefin-1234ze, a Next-Generation Propellant for Metered Dose Inhalers, in Participants with Asthma.

Journal of aerosol medicine and pulmonary drug delivery·2025

Same author

The Epidemiology of Combined Pulmonary Fibrosis and Emphysema among Mid-Atlantic Veterans.

Annals of the American Thoracic Society·2025

Same author

Author Response: Let It Breathe: Mastering Spontaneous Breathing Trials.

Respiratory care·2024

Same author

Variability in chest radiology interpretation between thoracic and non-thoracic radiologists: Implications for pulmonary fibrosis care.

Respiratory medicine·2024

Search research articles

Related Experiment Video

Updated: Feb 10, 2026

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Published on: June 21, 2024

Aerosol Delivery Devices for Obstructive Lung Diseases.

Roy A Pleasants¹, Dean R Hess²

¹Duke Clinical Research Institute and Durham Veterans Administration Pulmonary Division, Durham, North Carolina.

Respiratory Care

|May 26, 2018

Summary

Inhaled drug delivery is key for obstructive lung diseases. Optimizing inhaler selection and patient education improves medication effectiveness and aerosol science advancements enhance treatment understanding.

Keywords:

COPD asthma dry powder inhalers inhalational therapies lung deposition metered-dose inhalers nebulization patient education smart inhalers

More Related Videos

A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System

A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System

Published on: August 15, 2019

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

Related Experiment Videos

Last Updated: Feb 10, 2026

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Published on: June 21, 2024

A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System

A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System

Published on: August 15, 2019

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

Area of Science:

Pulmonary medicine
Aerosol science and technology

Background:

Obstructive lung diseases affect 15% of the US population.
Inhalation therapy is the primary treatment strategy for these conditions.
Aerosol delivery devices have advanced significantly over 60 years.

Purpose of the Study:

To review the evolution and current state of aerosol drug delivery devices.
To highlight challenges in optimal medication delivery via inhalation.
To emphasize the role of device selection and patient education in therapy optimization.

Main Methods:

Review of historical and current aerosol delivery devices.
Discussion of advanced measurement techniques in aerosol science.
Analysis of clinical application and patient education strategies.

Main Results:

Device evolution includes metered-dose inhalers, nebulizers, dry powder inhalers, soft mist inhalers, and smart devices.
Despite advancements, challenges in optimal aerosol delivery persist.
Emerging measurement methods like radio-scintigraphy and MRI enhance understanding of aerosol dynamics.

Conclusions:

Appropriate device selection and consistent patient education are crucial for effective inhaled therapy.
Continued advancements in aerosol science are vital for improving drug delivery to the lungs.
A comprehensive understanding of aerosol drug delivery science aids clinicians in optimizing patient treatment outcomes.